Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Baylor Scott & White Health · University of Mississippi · +36 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
312
total citations
- FWCI
- 97.07
- Percentile
- 100%
- References
- 50
Citations per year
Authors
32Topics & keywords
Topics
Keywords
- Heart failure with preserved ejection fraction
- Medicine
- Cardiology
- Internal medicine
- Semaglutide
- Placebo
- Heart failure
- Ejection fraction
UN Sustainable Development Goals
- Zero hunger
No related works found for this paper.
Funding
- UDU.S. Department of Defense
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZenecaAward: RE/18/6/34217
- SSanofi
- GSGilead Sciences
- APAlnylam Pharmaceuticals
- CBCSL Behring
- BSBoston Scientific Corporation
- RPRegeneron Pharmaceuticals
- ACAmarin Corporation
- CCytokinetics
- DDexcom
- BHBritish Heart FoundationAwards: 18/6/34217, RE/18/6/34217
- DFDeutsche ForschungsgemeinschaftAward: SFB1425
- DDaiichi-Sankyo
- GRGedeon Richter
- NNNovo NordiskAward: NCT04788511
- SServier
- SPSun Pharma
- HTHLS Therapeutics
- NINational Institutes of HealthAwards: P30AG021332, U54 HL160273, HL140731, HL127028, U01HL160272, U24AG059624, R01AG078153, SFB1425, HL149423, U01AG076928, R01 HL107577, R01 HL127028, R01 HL149423, HL107577, R01 HL140731
- ARAmerican Regent
- NHNational Heart, Lung, and Blood InstituteAwards: HL107577, R01 HL149423, R01 HL107577, R01 HL127028, R01 HL140731, U54 HL160273